11,954 Shares in Align Technology, Inc. $ALGN Bought by Edgestream Partners L.P.

Edgestream Partners L.P. bought a new stake in shares of Align Technology, Inc. (NASDAQ:ALGN – Free Report) in the 3rd quarter, according to its most recent filing with the SEC. The institutional investor bought 11,954 shares of the medical equipment provider’s stock, valued at approximately $1,689,000.

Several other large investors have also modified their holdings of ALGN. Assenagon Asset Management S.A. boosted its holdings in shares of Align Technology by 638.7% in the 3rd quarter. Assenagon Asset Management S.A. now owns 4,662,437 shares of the medical equipment provider’s stock valued at $629,469,000 after buying an additional 4,031,284 shares during the period. BlackRock Inc. acquired a new position in Align Technology during the 2nd quarter valued at about $745,370,000. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA grew its position in Align Technology by 3,162.7% in the 3rd quarter. Loring Wolcott & Coolidge Fiduciary Advisors LLP MA now owns 2,097,745 shares of the medical equipment provider’s stock worth $278,342,000 after purchasing an additional 2,033,451 shares during the last quarter. Vontobel Holding Ltd. grew its position in Align Technology by 69,628.9% in the 3rd quarter. Vontobel Holding Ltd. now owns 1,385,513 shares of the medical equipment provider’s stock worth $183,335,000 after purchasing an additional 1,383,526 shares during the last quarter. Finally, HighTower Advisors LLC increased its stake in shares of Align Technology by 17,371.1% in the third quarter. HighTower Advisors LLC now owns 1,348,416 shares of the medical equipment provider’s stock valued at $178,523,000 after purchasing an additional 1,340,698 shares during the period. Institutional investors own 88.43% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have recently weighed in on ALGN shares. Morgan Stanley cut their price target on Align Technology from $188.00 to $175.00 and set an “equal weight” rating on the stock in a report on Thursday, October 29th. Piper Sandler cut their price objective on shares of Align Technology from $235.00 to $205.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 21st. Raymond James Financial restated a “buy” rating on shares of Align Technology in a research report on Monday, October 5th. Leerink Partners lowered their price objective on shares of Align Technology from $235.00 to $215.00 and set an “outperform” rating on the stock in a research note on Wednesday, October 14th. Finally, Robert W. Baird downgraded Align Technology from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $218.00 to $162.00 in a research report on Thursday, October 15th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and eight have assigned a Hold rating to the company. According to data from MarketBeat, Align Technology presently has an average rating of “Moderate Buy” and an average price target of $193.08.

Check Out Our Latest Stock Report on Align Technology

Align Technology Trading Down 2.8%

Shares of ALGN opened at $155.13 on Friday. Align Technology, Inc. has a 1-year low of $132.63 and a 1-year high of $200.43. The stock has a market capitalization of $10.93 billion, a P/E ratio of 22.58, a P/E/G ratio of 2.01 and a beta of 1.74. The business’s 50-day moving average price is $152.50 and its 200 day moving average price is $168.54.

Align Technology (NASDAQ:ALGN – Get Free Report) last announced its earnings results on Wednesday, October 28th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.77 by $0.03. Align Technology had a net margin of 11.83% and a return on equity of 15.96%. The company had revenue of $1.01 billion during the quarter, compared to analysts’ expectations of $1 billion. During the same period last year, the company posted $2.61 earnings per share. The business’s revenue for the quarter was up 1.9% on a year-over-year basis. On average, research analysts predict that Align Technology, Inc. will post 9.21 earnings per share for the current year.

Align Technology Company Profile

(Free Report)

Align Technology, Inc. develops, manufactures and markets digital orthodontic and restorative dentistry products. Its best-known offering is the Invisalign system, which uses a series of custom-made clear aligners to straighten teeth. The company also sells Vivera retainers and iTero intraoral scanners, which support digital dental imaging and treatment planning. Founded in 1997, Align helped popularize clear-aligner orthodontic treatment as an alternative to traditional braces. Its digital dentistry portfolio also includes exocad software, used by dental professionals and laboratories to design dental restorations.

See Also

Want to see what other hedge funds are holding ALGN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Align Technology, Inc. (NASDAQ:ALGN – Free Report).

Institutional Ownership by Quarter for Align Technology (NASDAQ:ALGN)

Receive News & Ratings for Align Technology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Align Technology and related companies with MarketBeat.com's FREE daily email newsletter.